Tuberculosis Prophylaxis in the Homeless--A Controlled Trial
NCT00005737 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-03-16
Summary
To conduct a three-arm, randomized controlled trial of methods to improve adherence to biweekly directly observed prophylaxis (DOPT) for tuberculosis in homeless adults in San Francisco.
Conditions
- Lung Diseases
- Tuberculosis
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Andrew Moss · University of California
Eligibility
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1995-09-30
- Completion
- 1999-08-31
More Related Trials
-
Tuberculosis Prevention for HIV Infected Adults
NCT00057122 ·Status: COMPLETED ·Phase: PHASE3
-
Ultra-Short Regimen for Elderly DS-TB
NCT07076225 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Tuberculosis in a Multiethnic Inner City Population
NCT00005379 ·Status: COMPLETED
-
Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers
NCT05537038 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis
NCT03678688 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TB
NCT03350048 ·Status: COMPLETED
-
Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis
NCT00216333 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Community Active Case Finding Strategies for Detection of Tuberculosis in Cambodia
NCT04094350 ·Status: COMPLETED ·Phase: NA
-
A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis
NCT00216385 ·Status: UNKNOWN ·Phase: PHASE3
-
Finding and Treating Unsuspected and Resistant TB to Reduce Hospital Transmission
NCT02355223 ·Status: UNKNOWN ·Phase: NA
-
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
NCT06022146 ·Status: RECRUITING ·Phase: PHASE3
-
An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment
NCT03266003 ·Status: COMPLETED ·Phase: NA
-
Pharmacist-led Digital Interventions to Improve Tuberculosis Treatment Adherence
NCT07069387 ·Status: RECRUITING ·Phase: NA
-
Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis
NCT05896930 ·Status: COMPLETED ·Phase: PHASE2
-
Increased Tuberculosis Case Detection - DiOpTB
NCT06437184 ·Status: RECRUITING ·Phase: NA
-
First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b
NCT06050356 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Accuracy and Consequences of Using Trial-of-antibiotics for TB Diagnosis (ACT-TB Study)
NCT03545373 ·Status: COMPLETED ·Phase: PHASE3
-
Training Protocol on the Natural History of Tuberculosis
NCT01212003 ·Status: RECRUITING
-
A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
NCT07209761 ·Status: RECRUITING ·Phase: PHASE3
-
A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis
NCT00317330 ·Status: COMPLETED ·Phase: PHASE3
-
Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)
NCT05401071 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Ultra Curto (Ultra Short) TB Prevention Therapy
NCT04703075 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Safety, Tolerability, PK of TBAJ-587 in Healthy Adults
NCT04890535 ·Status: COMPLETED ·Phase: PHASE1
-
Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis
NCT05007795 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial
NCT05017324 ·Status: UNKNOWN ·Phase: NA